Clinical Features

Emerging Treatments for Colorectal Cancer: Advancing Towards Precision Therapy

Colorectal cancer (CRC) is the third most commonly diagnosed cancer and second leading cause of cancer-related mortality worldwide.

Colorectal

Introduction: Colorectal cancer (CRC) is the third most commonly diagnosed cancer and second leading cause of cancer-related mortality worldwide. In 2020 alone, over 1.9 million new cases and nearly 935,000 deaths were reported globally and the global burden of CRC is projected to rise by 60% by 2030.1 Risk factors for CRC include both lifestyle and genetic factors. Modifiable risks include diets high in red or processed meats, low physical activity, obesity, smoking, and excessive alcohol use. Family history, genetic conditions like Lynch syndrome or familial

adenomatous polyposis (FAP), and inflammatory bowel diseases also increase susceptibility.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free